Skip to content

AIM round-up: Windar Photonics, Mineral & Financial, C4X Discovery

AIM round-up: Windar Photonics, Mineral & Financial, C4X Discovery

London’s AIM Index has posted an upbeat start to the week, outperforming not only the main board but also other indices on both sides of the Atlantic. At the bell, the junior market was a little over four points higher at 851.25.

  • Windar Photonics +88%
  • Mineral & Financial +20%
  • C4X Discovery +17%
  • Petroneft -33%
  • Inspiration Healthcare -26%

Windar Photonics LON:WPHO topped the board today, adding 88% in the wake of news that its shares had been relisted on the stock market. They were suspended back in the summer following a delay in publication of audited accounts. The company also managed to raise fresh capital at 15p per share which offered some further support.

Mineral & Financial LON:MAFL added 20% on the day following an update relating to the financing of a project in Portugal. The 10% closing spread suggests that demand for the stock was a little lop-sided.


C4X Discovery LON:C4XD added 17%, getting the day’s notable mention as a result. The company this morning announced the signing of a deal worth as much as $400m with AstraZeneca, although gains earlier in the session were rather more impressive.

Petroneft [LON:PTR] was the day’s laggard, off 33% at the bell. That extended losses seen ahead of the weekend break after the company advised of financing difficulties. With spiralling debts there’s growing speculation that creditors will end up assuming ownership, wiping out equity holders.

Inspiration Healthcare LON:IHC slipped 26% following an update on trading which was published this morning. The company flags issues with distribution and manufacturing, getting in the way of fulfilling some significant orders. News of cost savings have therefore had limited impact on sentiment for the stock.

Share this article

Invest with these platforms

Hargreaves Lansdown

IG

Interactive Brokers

Interactive Investor

Charles Stanley

IG

Interactive Brokers

Charles Stanley

Looking for great investing ideas? Get our free newsletter.

This article does not constitute investment advice.  Do your own research or consult a professional advisor.

Learn with our free 'How to' Guides

Our latest in-depth company reports

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

WisdomTree
eToro
Schroders
ARK
Plus500

CME Group
aberdeen
FP Markets
Pepperstone
Aquis

Back To Top